- Home
- PHVS vs SLG Comparison
PHVS vs SLG Comparison
Compare PHVS & SLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- SLG
- Stock Information
- Founded
- PHVS 2015
- SLG 1980
- Country
- PHVS Switzerland
- SLG United States
- Employees
- PHVS N/A
- SLG N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- SLG Real Estate Investment Trusts
- Sector
- PHVS Health Care
- SLG Real Estate
- Exchange
- PHVS Nasdaq
- SLG Nasdaq
- Market Cap
- PHVS 980.3M
- SLG 4.6B
- IPO Year
- PHVS 2021
- SLG 1997
- Fundamental
- Price
- PHVS $18.60
- SLG $62.13
- Analyst Decision
- PHVS Buy
- SLG Hold
- Analyst Count
- PHVS 6
- SLG 16
- Target Price
- PHVS $37.17
- SLG $66.50
- AVG Volume (30 Days)
- PHVS 35.9K
- SLG 1.2M
- Earning Date
- PHVS 08-13-2025
- SLG 07-16-2025
- Dividend Yield
- PHVS N/A
- SLG 4.92%
- EPS Growth
- PHVS N/A
- SLG N/A
- EPS
- PHVS N/A
- SLG N/A
- Revenue
- PHVS N/A
- SLG $648,551,000.00
- Revenue This Year
- PHVS N/A
- SLG N/A
- Revenue Next Year
- PHVS N/A
- SLG $2.45
- P/E Ratio
- PHVS N/A
- SLG N/A
- Revenue Growth
- PHVS N/A
- SLG N/A
- 52 Week Low
- PHVS $11.51
- SLG $45.15
- 52 Week High
- PHVS $25.50
- SLG $82.81
- Technical
- Relative Strength Index (RSI)
- PHVS 60.00
- SLG 52.10
- Support Level
- PHVS $16.72
- SLG $60.52
- Resistance Level
- PHVS $17.53
- SLG $63.75
- Average True Range (ATR)
- PHVS 0.93
- SLG 1.83
- MACD
- PHVS 0.07
- SLG -0.43
- Stochastic Oscillator
- PHVS 92.86
- SLG 49.24
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About SLG SL Green Realty Corp
SL Green Realty is one of the largest Manhattan property owners and landlords, with interest in around 32 million square feet of wholly owned and joint-venture office space. The company has additional property exposure through its limited portfolio of well-located retail space. It operates as a real estate investment trust.